Alterity Therapeutics Limited (ATHE) Financials

$4.84

north_east
$0.61 (14.42%)
Day's range
$4.28
Day's range
$4.98
$10M$10M$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20MEarning201820182019201920202020202120212022202220232023202420240%0%-2000%-2000%-4000%-4000%-6000%-6000%-8000%-8000%-10000%-10000%-12000%-12000%Profit Margin
Profit Margin
Revenue
Earnings

ATHE Income statement / Annual

Last year (2024), Alterity Therapeutics Limited's total revenue was $4.02 M, an increase of 2.63% from the previous year. In 2024, Alterity Therapeutics Limited's net income was -$19.12 M. See Alterity Therapeutics Limited,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 06/30/2024 06/30/2023 06/30/2022 06/30/2021 06/30/2020 06/30/2019 06/30/2018 06/30/2017 06/30/2016 06/30/2015
Operating Revenue $4.02 M $3.92 M $5.12 M $4.34 M $0.00 $108,538.00 $201,174.00 $132,396.00 $142,657.00 $176,842.00
Cost of Revenue $214,304.00 $285,067.00 $364,665.00 $360,026.00 $112,427.00 $29,696.00 $21,799.00 $21,328.00 $22,810.00 $257,299.00
Gross Profit $3.80 M $3.63 M $4.76 M $3.98 M -$112,427.00 $78,842.00 $179,375.00 $111,068.00 $119,847.00 -$80,457.00
Gross Profit Ratio 0.95 0.93 0.93 0.92 0 0.73 0.89 0.84 0.84 -0.45
Research and Development Expenses $18.64 M $13.20 M $14.75 M $12.28 M $10.10 M $12.98 M $6.70 M $5.70 M $9.59 M $12.30 M
General & Administrative Expenses $4.77 M $4.99 M $5.43 M $6.85 M $3.33 M $4.28 M $4.32 M $3.95 M $3.59 M $4.06 M
Selling & Marketing Expenses -$9,674.00 $51,484.00 $79,329.00 $21,812.00 $0.00 $0.00 $0.00 $0.00 $0.00 $87,851.00
Selling, General & Administrative Expenses $4.76 M $5.04 M $5.51 M $6.87 M $3.33 M $4.28 M $4.32 M $3.95 M $3.59 M $4.15 M
Other Expenses $0.00 -$282,964.00 -$364,665.00 -$360,026.00 -$3.36 M -$4.79 M $2.90 M -$241,892.00 -$241,954.00 -$170,977.00
Operating Expenses $23.41 M $17.35 M $17.54 M $19.31 M $10.07 M $12.47 M $11.10 M $6.77 M $8.49 M $10.61 M
Cost And Expenses $23.62 M $17.63 M $17.90 M $19.67 M $10.07 M $12.47 M $11.10 M $6.77 M $8.49 M $10.61 M
Interest Income $268,419.00 $16,436.00 $2,504.00 $20,676.00 $17,117.00 $108,538.00 $201,174.00 $132,396.00 $142,657.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $147,529.00 $102,263.00 $54,214.00 $75,369.00 $112,427.00 $29,696.00 $21,799.00 $21,328.00 $22,810.00 $31,587.00
EBITDA -$19.57 M -$17.51 M -$17.39 M -$19.36 M -$13.34 M -$12.77 M -$11.37 M -$6.86 M -$8.56 M -$10.57 M
EBITDA Ratio -4.87 -4.47 -3.39 -4.46 0 -117.62 -56.52 -51.82 -60.03 -59.8
Operating Income Ratio -4.88 -3.74 -3.03 -3.5 0 -117.14 -38.62 -51.98 -60.19 -59.01
Total Other Income/Expenses Net $524,333.00 $904,682.00 $2.72 M -$133,036.00 $428,684.00 $324,637.00 -$127,858.00 -$786,284.00 $811,971.00 $4.68 M
Income Before Tax -$19.08 M -$13.70 M -$12.78 M -$15.31 M -$10.06 M -$12.34 M -$8.27 M -$7.54 M -$7.73 M -$5.89 M
Income Before Tax Ratio -4.75 -3.5 -2.49 -3.53 0 -113.67 -41.09 -56.97 -54.18 -33.28
Income Tax Expense $46,088.00 $104,459.00 $70,008.00 -$4.13 M -$362,188.00 -$376,031.00 -$495,440.00 $660,213.00 -$857,248.00 -$170,977.00
Net Income -$19.12 M -$13.81 M -$12.85 M -$15.31 M -$9.70 M -$11.96 M -$8.27 M -$7.54 M -$7.73 M -$5.89 M
Net Income Ratio -4.76 -3.53 -2.51 -3.53 0 -110.21 -41.09 -56.97 -54.18 -33.28
EPS -3.12 -3.42 -3.18 -5.4 -6.48 -11.64 -9.3 -8.46 -8.7 -7.02
EPS Diluted -3.12 -3.42 -3.18 -5.4 -6.48 -11.64 -9.3 -8.46 -8.7 -7.02
Weighted Average Shares Out $6.08 M $4.05 M $4.01 M $2.83 M $1.49 M $1.03 M $888,788.00 $889,819.00 $888,515.00 $837,858.00
Weighted Average Shares Out Diluted $6.08 M $4.05 M $4.01 M $2.83 M $1.49 M $1.03 M $889,819.00 $889,819.00 $889,819.00 $837,858.00
Link